Heart Test Laboratories, Inc. announced that it will receive $934,997 in funding on November 15, 2023. The company will issue Common Shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. The company represents issuance of 4,854,853 shares of common stock, 710,605 pre-funded warrants and 914,148 warrants, in consideration of the right to commercialize a series of licenses, based on a closing price of $0.16 per share as of such issuance.